Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 31, 1997

Primary Completion Date

January 31, 2004

Study Completion Date

June 30, 2009

Conditions
Prostate Cancer
Interventions
DRUG

flutamide

DRUG

goserelin

DRUG

leuprolide acetate

RADIATION

low-LET photon therapy

Trial Locations (12)

10021

Memorial Sloan-Kettering Cancer Center, New York

27710

Duke Comprehensive Cancer Center, Durham

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

60637

University of Chicago Cancer Research Center, Chicago

94115-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

20307-5000

Walter Reed Army Medical Center, Washington D.C.

02115

Dana-Farber Cancer Institute, Boston

02215

Joint Center for Radiation Therapy, Boston

07503

St. Joseph's Hospital and Medical Center, Paterson

14263-0001

Roswell Park Cancer Institute, Buffalo

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

29425-0721

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER